Jason A Jarzembowski
Overview
Explore the profile of Jason A Jarzembowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jarzembowski J, Webster F, Beiske K, Cohn S, de Krijger R, Irwin M, et al.
Histopathology
. 2025 Feb;
PMID: 39989174
Peripheral neuroblastic tumours are the most common extracranial solid neoplasms occurring in children. Proper classification is critical for directing therapy and predicting prognosis. Nonetheless, their relative rarity makes accurate pathological...
2.
Jing X, Jia S, Teng M, Day B, Afolayan A, Jarzembowski J, et al.
Am J Respir Cell Mol Biol
. 2023 Oct;
70(2):94-109.
PMID: 37874230
Oxidative stress, inflammation, and endoplasmic reticulum (ER) stress sequentially occur in bronchopulmonary dysplasia (BPD), and all result in DNA damage. When DNA damage becomes irreparable, tumor suppressors increase, followed by...
3.
Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, et al.
Neurooncol Adv
. 2023 Jul;
5(1):vdad076.
PMID: 37476329
Background: Central nervous system (CNS) cancer is the 10th leading cause of cancer-associated deaths for adults, but the leading cause in pediatric patients and young adults. The variety and complexity...
4.
Schilter K, Smith B, Nie Q, Stoll K, Felix J, Jarzembowski J, et al.
Front Genet
. 2023 Feb;
14:1067457.
PMID: 36845394
Next-Generation Sequencing (NGS) allows rapid analysis of multiple genes for the detection of clinically actionable variants. This study reports the analytical validation of a targeted pan cancer NGS panel CANSeqKids...
5.
Lyvannak S, Sereyleak B, Farrilend P, Thy V, Keller F, Jarzembowski J, et al.
J Pediatr Hematol Oncol
. 2023 Feb;
45(2):103-104.
PMID: 36730949
No abstract available.
6.
Suster D, Mackinnon A, Jarzembowski J, Carrera G, Suster S, Klein M
Hum Pathol
. 2022 Mar;
125:68-78.
PMID: 35337839
Seventeen cases of epithelioid osteoblastoma were reviewed. The tumors most commonly arose from the vertebrae (7 cases), followed by the mandible (3), sacrum (2), bones of the foot (2), and...
7.
Hopp A, Tetzlaff J, Kopidlansky K, Leventaki V, Parsons L, Bone K, et al.
Am J Clin Pathol
. 2022 Jan;
158(1):81-95.
PMID: 35050350
Objectives: Partnerships between low- to middle-income countries (LMICs) and high-income countries (HICs) is one strategy to mitigate observed health disparities. Cambodia's Angkor Hospital for Children (AHC), an LMIC institution, faces...
8.
Pfister S, Reyes-Mugica M, Chan J, Hasle H, Lazar A, Rossi S, et al.
Cancer Discov
. 2021 Dec;
12(2):331-355.
PMID: 34921008
Pediatric tumors are uncommon, yet are the leading cause of cancer-related death in childhood. Tumor types, molecular characteristics, and pathogenesis are unique, often originating from a single genetic driver event....
9.
Foomani F, Jarzembowski J, Mostaghimi S, Mehrvar S, Kumar S, Ranji M
IEEE J Transl Eng Health Med
. 2021 Aug;
9:1800407.
PMID: 34462673
Background: Mitochondrial [Formula: see text]-oxidation of fatty acids is the primary energy source for the heart and carried out by Hydroxy Acyl-CoA Dehydrogenase (HADH) encoded trifunctional protein. Mutations in the...
10.
Weiss B, Yanik G, Naranjo A, Zhang F, Fitzgerald W, Shulkin B, et al.
Pediatr Blood Cancer
. 2021 May;
68(10):e29117.
PMID: 34028986
Introduction: I-meta-iodobenzylguanidine ( I-MIBG) is effective in relapsed neuroblastoma. The Children's Oncology Group (COG) conducted a pilot study (NCT01175356) to assess tolerability and feasibility of induction chemotherapy followed by I...